XML 48 R20.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Expected Credit Losses on Financial Assets and Reconciliation of carrying amount | 12 Months Ended
--- | ---
Dec. 31, 2023
Disclosure of fair value measurement of assets [abstract] |
Expected Credit Losses on Financial Assets and Reconciliation of carrying amount | Expected Credit Losses on Financial Assets and Reconciliation of carrying amount a) Reconciliation of carrying amount of Financial Assets It is presented below the reconciliation of gross carrying amount of financial assets through other comprehensive income and financial assets measured at amortized cost – that have their ECLs (Expected Credit Losses) measured using the three-stage model and the low credit risk simplification.
Stage 1 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 35,150,599 |  |  | 8,543,238 |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 43,693,837 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 9,275,027 |  |  | (2,413,534) |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 6,861,493 |
Securities purchased under agreements to resell |  | 7,606,501 |  |  | 7,285,280 |  |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  |  |  | 14,891,781 |
Loans and credit card operations |  | 21,168,048 |  |  | 5,678,561 |  |  | 1,082,998 |  |  | (1,800,466) |  |  | (193,066) |  |  | 518,241 |  |  | 27 |  |  | (6,975) |  |  | 26,447,368 |
Total on-balance exposures |  | 73,200,175 |  |  | 19,093,545 |  |  | 1,082,998 |  |  | (1,800,466) |  |  | (193,066) |  |  | 518,241 |  |  | 27 |  |  | (6,975) |  |  | 91,894,479 |
Off-balance exposures (credit card limits) |  | 4,759,298 |  |  | 3,670,075 |  |  | 201,949 |  |  | (495,087) |  |  | (5,526) |  |  | 193,171 |  |  | 17 |  |  | — |  |  | 8,323,897 |
Total exposures |  | 77,959,473 |  |  | 22,763,620 |  |  | 1,284,947 |  |  | (2,295,553) |  |  | (198,592) |  |  | 711,412 |  |  | 44 |  |  | (6,975) |  |  | 100,218,376 |
Stage 2 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 1,073,170 |  |  | (111,875) |  |  | 2,734 |  |  | (518,241) |  |  | (33,238) |  |  | 1,800,466 |  |  | 117 |  |  | (10,202) |  |  | 2,202,931 |
Total on-balance exposures |  | 1,073,170 |  |  | (111,875) |  |  | 2,734 |  |  | (518,241) |  |  | (33,238) |  |  | 1,800,466 |  |  | 117 |  |  | (10,202) |  |  | 2,202,931 |
Off-balance exposures (credit card limits) |  | 255,539 |  |  | 25,490 |  |  | 308 |  |  | (193,171) |  |  | (8) |  |  | 495,087 |  |  | 25 |  |  | — |  |  | 583,270 |
Total exposures |  | 1,328,709 |  |  | (86,385) |  |  | 3,042 |  |  | (711,412) |  |  | (33,246) |  |  | 2,295,553 |  |  | 142 |  |  | (10,202) |  |  | 2,786,201 |
Stage 3 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 19,319 |  |  | (11,003) |  |  | 18,004 |  |  | (27) |  |  | (117) |  |  | 193,066 |  |  | 33,238 |  |  | (20,890) |  |  | 231,590 |
Total on-balance exposures |  | 19,319 |  |  | (11,003) |  |  | 18,004 |  |  | (27) |  |  | (117) |  |  | 193,066 |  |  | 33,238 |  |  | (20,890) |  |  | 231,590 |
Off-balance exposures (credit card limits) |  | — |  |  | (31) |  |  | 79 |  |  | (17) |  |  | (25) |  |  | 5,526 |  |  | 8 |  |  | — |  |  | 5,540 |
Total exposures |  | 19,319 |  |  | (11,034) |  |  | 18,083 |  |  | (44) |  |  | (142) |  |  | 198,592 |  |  | 33,246 |  |  | (20,890) |  |  | 237,130 |
Consolidated Stages |  | Balance at December 31, 2022 |  | Purchases / (Settlements) |  | Business Combination |  | Write-Off |  | Closing balance December 31, 2023
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |
Securities |  | 35,150,599 |  |  | 8,543,238 |  |  | — |  |  | — |  |  | 43,693,837 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |
Securities |  | 9,275,027 |  |  | (2,413,534) |  |  | — |  |  | — |  |  | 6,861,493 |
Securities purchased under agreements to resell |  | 7,606,501 |  |  | 7,285,280 |  |  | — |  |  | — |  |  | 14,891,781 |
Loans and credit card operations |  | 22,260,537 |  |  | 5,555,684 |  |  | 1,103,736 |  |  | (38,068) |  |  | 28,881,889 |
Total on-balance exposures |  | 74,292,664 |  |  | 18,970,668 |  |  | 1,103,736 |  |  | (38,068) |  |  | 94,329,000 |
Off-balance exposures (credit card limits) |  | 5,014,837 |  |  | 3,695,534 |  |  | 202,336 |  |  | — |  |  | 8,912,707 |
Total exposures |  | 79,307,501 |  |  | 22,666,202 |  |  | 1,306,072 |  |  | (38,068) |  |  | 103,241,707 |
Stage 1 |  | Balance at December 31, 2021 |  | Acquisition / (Settlements) |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Closing balance December 31, 2022
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 32,339,904 |  |  | 2,810,695 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 35,150,599 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 2,241,304 |  |  | 7,033,723 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9,275,027 |
Securities purchased under agreements to resell |  | 8,897,100 |  |  | (1,290,599) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7,606,501 |
Loans and credit card operations |  | 12,153,549 |  |  | 9,522,224 |  |  | (945,055) |  |  | (12,373) |  |  | 449,698 |  |  | 5 |  |  | 21,168,048 |
Total on-balance exposures |  | 55,631,857 |  |  | 18,076,043 |  |  | (945,055) |  |  | (12,373) |  |  | 449,698 |  |  | 5 |  |  | 73,200,175 |
Off-balance exposures (credit card limits) |  | 1,307,986 |  |  | 3,639,893 |  |  | (241,705) |  |  | — |  |  | 53,124 |  |  | — |  |  | 4,759,298 |
Total exposures |  | 56,939,843 |  |  | 21,715,936 |  |  | (1,186,760) |  |  | (12,373) |  |  | 502,822 |  |  | 5 |  |  | 77,959,473 |
Stage 2 |  | Balance at December 31, 2021 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Closing balance December 31, 2022
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 686,994 |  |  | (102,544) |  |  | (449,698) |  |  | (6,642) |  |  | 945,055 |  |  | 5 |  |  | 1,073,170 |
Total on-balance exposures |  | 686,994 |  |  | (102,544) |  |  | (449,698) |  |  | (6,642) |  |  | 945,055 |  |  | 5 |  |  | 1,073,170 |
Off-balance exposures (credit card limits) |  | 59,408 |  |  | 7,548 |  |  | (53,125) |  |  | — |  |  | 241,705 |  |  | 3 |  |  | 255,539 |
Total exposures |  | 746,402 |  |  | (94,996) |  |  | (502,823) |  |  | (6,642) |  |  | 1,186,760 |  |  | 8 |  |  | 1,328,709 |
Stage 3 |  | Balance at December 31, 2021 |  | Acquisition / (Settlements) |  | Transfer to stage 1 |  | Transfer to stage 2 |  | Transfer from stage 1 |  | Transfer from stage 2 |  | Closing balance December 31, 2022
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 3,494 |  |  | (3,180) |  |  | (5) |  |  | (5) |  |  | 12,373 |  |  | 6,642 |  |  | 19,319 |
Total on-balance exposures |  | 3,494 |  |  | (3,180) |  |  | (5) |  |  | (5) |  |  | 12,373 |  |  | 6,642 |  |  | 19,319 |
Off-balance exposures (credit card limits) |  | 5 |  |  | (2) |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | — |
Total exposures |  | 3,499 |  |  | (3,182) |  |  | (5) |  |  | (8) |  |  | 12,373 |  |  | 6,642 |  |  | 19,319 |
Consolidated Stages |  | Balance at December 31, 2021 |  | Purchases / (Settlements) |  | Closing balance December 31, 2022
Financial assets at fair value through other comprehensive income |  |  |  |  |  |
Securities |  | 32,339,904 |  |  | 2,810,695 |  |  | 35,150,599 |
Financial assets amortized cost |  |  |  |  |  |
Securities |  | 2,241,304 |  |  | 7,033,723 |  |  | 9,275,027 |
Securities purchased under agreements to resell |  | 8,897,100 |  |  | (1,290,599) |  |  | 7,606,501 |
Loans and credit card operations |  | 12,844,037 |  |  | 9,416,500 |  |  | 22,260,537 |
Total on-balance exposures |  | 56,322,345 |  |  | 17,970,319 |  |  | 74,292,664 |
Off-balance exposures (credit card limits) |  | 1,367,399 |  |  | 3,647,438 |  |  | 5,014,837 |
Total exposures |  | 57,689,744 |  |  | 21,617,757 |  |  | 79,307,501 |
The following table presents the gross carrying amount of financial assets measured at amortized cost, which that have their ECLs measured using the simplified approach:
Operations |  | 2023 |  | 2022
Financial assets amortized cost |  |  |  |
Securities trading and intermediation |  | 3,047,011 |  |  | 3,376,179 |
Accounts Receivable |  | 745,097 |  |  | 632,673 |
Other financial assets (i) |  | 4,263,947 |  |  | 3,568,298 |
Total |  | 8,056,055 |  |  | 7,577,150 |
(i)During the year ended December 31, 2023, there was R$ 1,101 of other financial assets write-off. b) Expected credit loss The table below presents the changes in ECLs, measured according to the three stage model, for assets classified as Financial assets through other comprehensive income and Financial assets measured at amortized cost in the period ended December 31, 2023 and December 31, 2022, segregated by stages:
Stage 1 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 8,077 |  |  | 4,122 |  |  | — |  | — |  | — |  | — |  | — |  |  | — |  |  | 12,199 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 2,924 |  |  | 3,148 |  |  | — |  | — |  | — |  | — |  | — |  |  | — |  |  | 6,072 |
Securities purchased under agreements to resell |  | 2,681 |  |  | 122 |  |  | — |  | — |  | — |  | — |  | — |  |  | — |  |  | 2,803 |
Loans and credit card operations |  | 21,312 |  |  | 223,234 |  |  | 27,499 |  | (63,095) |  | (148,305) |  | 1,173 |  | 1 |  |  | (6,975) |  |  | 54,844 |
Total on-balance exposures |  | 34,994 |  |  | 230,626 |  |  | 27,499 |  | (63,095) |  | (148,305) |  | 1,173 |  | 1 |  |  | (6,975) |  |  | 75,918 |
Off-balance exposures (credit card limits) |  | 4,800 |  |  | 8,064 |  |  | 4,303 |  | (5,427) |  | (3,765) |  | 187 |  | — |  |  | — |  |  | 8,162 |
Other off-balance exposures |  | 15,214 |  |  | — |  |  | — |  | — |  | (15,214) |  | — |  | — |  |  | — |  |  | — |
Total exposures |  | 55,008 |  |  | 238,690 |  |  | 31,802 |  | (68,522) |  | (167,284) |  | 1,360 |  | 1 |  |  | (6,975) |  |  | 84,080 |
Stage 2 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 7,656 |  |  | 43,159 |  |  | 807 |  |  | (1,173) |  | (28,663) |  | 63,095 |  | 17 |  | (10,202) |  |  | 74,696 |
Total on-balance exposures |  | 7,656 |  |  | 43,159 |  |  | 807 |  |  | (1,173) |  | (28,663) |  | 63,095 |  | 17 |  | (10,202) |  |  | 74,696 |
Off-balance exposures (credit card limits) |  | 1,428 |  |  | (467) |  |  | 3 |  |  | (187) |  | (1) |  | 5,427 |  | — |  | — |  |  | 6,203 |
Total exposures |  | 9,084 |  |  | 42,692 |  |  | 810 |  |  | (1,360) |  | (28,664) |  | 68,522 |  | 17 |  | (10,202) |  |  | 80,899 |
Stage 3 |  | Balance at December 31, 2022 |  | Acquisition / (Settlements) |  | Business Combination |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | Write-Off |  | Closing balance December 31, 2023
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 14,181 |  |  | (3,226) |  |  | 15,268 |  |  | (1) |  | (17) |  | 148,304 |  | 28,663 |  | (20,891) |  |  | 182,281 |
Total on-balance exposures |  | 14,181 |  |  | (3,226) |  |  | 15,268 |  |  | (1) |  | (17) |  | 148,304 |  | 28,663 |  | (20,891) |  |  | 182,281 |
Off-balance exposures (credit card limits) |  | — |  |  | (18) |  |  | 18 |  |  | — |  | — |  | 3,766 |  | 1 |  | — |  |  | 3,767 |
Other off-balance exposures |  | — |  |  | 38,891 |  |  | — |  |  | — |  | — |  | 15,214 |  | — |  | (54,105) |  |  | — |
Total exposures |  | 14,181 |  |  | 35,647 |  |  | 15,286 |  |  | (1) |  | (17) |  | 167,284 |  | 28,664 |  | (74,996) |  |  | 186,048 |
Consolidated Stages |  | Balance at December 31, 2022 |  | Increase / (Reversal) |  | Business Combination |  | Write-Off |  | Closing balance December 31, 2023
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |
Securities |  | 8,077 |  |  | 4,122 |  |  | — |  |  | — |  |  | 12,199 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |
Securities |  | 2,924 |  |  | 3,148 |  |  | — |  |  | — |  |  | 6,072 |
Securities purchased under agreements to resell |  | 2,681 |  |  | 122 |  |  | — |  |  | — |  |  | 2,803 |
Loans and credit card operations |  | 43,149 |  |  | 263,168 |  |  | 43,573 |  |  | (38,068) |  |  | 311,822 |
Total on-balance exposures |  | 56,831 |  |  | 270,560 |  |  | 43,573 |  |  | (38,068) |  |  | 332,896 |
Off-balance exposures (credit card limits) |  | 6,228 |  |  | 7,579 |  |  | 4,325 |  |  | — |  |  | 18,132 |
Other off-balance exposures |  | 15,214 |  |  | 38,890 |  |  | — |  |  | (54,104) |  |  | — |
Total exposures |  | 78,273 |  |  | 317,029 |  |  | 47,898 |  |  | (92,172) |  |  | 351,028 |
Stage 1 |  | ECL at December 31, 2021 |  | Increase / (Reversal) |  | Transfer to stage 2 |  | Transfer to stage 3 |  | Transfer from stage 2 |  | Transfer from stage 3 |  | ECL at December 31, 2022
Financial assets at fair value through other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 7,527 |  |  | 550 |  |  | — |  | — |  | — |  | — |  | 8,077 |
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities |  | 2,497 |  |  | 427 |  |  | — |  | — |  | — |  | — |  | 2,924 |
Securities purchased under agreements to resell |  | 2,569 |  |  | 112 |  |  | — |  | — |  | — |  | — |  | 2,681 |
Loans and credit card operations |  | 13,957 |  |  | 21,827 |  |  | (6,940) |  | (8,624) |  | 1,092 |  | — |  | 21,312 |
Total on-balance exposures |  | 26,550 |  |  | 22,916 |  |  | (6,940) |  | (8,624) |  | 1,092 |  | — |  | 34,994 |
Off-balance exposures (credit card limits) |  | 726 |  |  | 5,413 |  |  | (1,394) |  | — |  | 55 |  | — |  | 4,800 |
Other off-balance exposures |  | — |  |  | 15,214 |  |  | — |  | — |  | — |  | — |  | 15,214 |
Total exposures |  | 27,276 |  |  | 43,543 |  |  | (8,334) |  | (8,624) |  | 1,147 |  | — |  | 55,008 |
Stage 2 |  | ECL at December 31, 2021 |  | Increase / (Reversal) |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | ECL at December 31, 2022
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 7,242 |  |  | (127) |  |  | (1,091) |  |  | (5,308) |  |  | 6,940 |  |  | — |  |  | 7,656 |
Total on-balance exposures |  | 7,242 |  |  | (127) |  |  | (1,091) |  |  | (5,308) |  |  | 6,940 |  |  | — |  |  | 7,656 |
Off-balance exposures (credit card limits) |  | 288 |  |  | (198) |  |  | (56) |  |  | — |  |  | 1,394 |  |  | — |  |  | 1,428 |
Total exposures |  | 7,530 |  |  | (325) |  |  | (1,147) |  |  | (5,308) |  |  | 8,334 |  |  | — |  |  | 9,084 |
Stage 3 |  | ECL at December 31, 2021 |  | Increase / (Reversal) |  | Transfer to stage 1 |  | Transfer to stage 3 |  | Transfer from stage 1 |  | Transfer from stage 3 |  | ECL at December 31, 2022
Financial assets amortized cost |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans and credit card operations |  | 2,197 |  |  | (1,948) |  |  | — |  | — |  | 8,624 |  | 5,308 |  | 14,181 |
Total on-balance exposures |  | 2,197 |  |  | (1,948) |  |  | — |  | — |  | 8,624 |  | 5,308 |  | 14,181 |
Total exposures |  | 2,197 |  |  | (1,948) |  |  | — |  | — |  | 8,624 |  | 5,308 |  | 14,181 |
Consolidated Stages |  | ECL at December 31, 2021 |  | Increase / (Reversal) |  | ECL at December 31, 2022
Financial assets at fair value through other comprehensive income |  |  |  |  |  |
Securities |  | 7,527 |  |  | 550 |  |  | 8,077 |
Financial assets amortized cost |  |  |  |  |  |
Securities |  | 2,497 |  |  | 427 |  |  | 2,924 |
Securities purchased under agreements to resell |  | 2,569 |  |  | 112 |  |  | 2,681 |
Loans and credit card operations |  | 23,396 |  |  | 19,753 |  |  | 43,149 |
Total on-balance exposures |  | 35,989 |  |  | 20,842 |  |  | 56,831 |
Off-balance exposures (credit card limits) |  | 1,014 |  |  | 5,214 |  |  | 6,228 |
Other off-balance exposures |  | — |  |  | 15,214 |  |  | 15,214 |
Total exposures |  | 37,003 |  |  | 41,270 |  |  | 78,273 |
The table below presents the ECLs for the financial assets measured according to simplified approach in the period ended December 31, 2023 and December 31, 2022:
Expected Credit Losses |  | 2023 |  | 2022
Financial assets amortized cost |  |  |  |
Securities trading and intermediation |  | 114,692 |  |  | 105,179 |
Accounts Receivable |  | 63,907 |  |  | 34,786 |
Other financial assets |  | 55,204 |  |  | 51,109 |
Total |  | 233,803 |  |  | 191,074 |
c) Expected credit losses segregated by products The table below presents the expected credit losses for 2023 and 2022, segregated by products:
Expected Credit Losses |  | 2023 |  | 2022
Financial assets at fair value through other comprehensive income |  | 12,199 |  |  | 8,077 |
Securities |  | 12,199 |  |  | 8,077 |
Financial assets amortized cost |  | 554,501 |  |  | 239,828 |
Securities |  | 6,072 |  |  | 2,924 |
Securities purchased under agreements to resell |  | 2,803 |  |  | 2,681 |
Loans and credit card operations |  | 311,823 |  |  | 43,149 |
Securities trading and intermediation |  | 114,692 |  |  | 105,179 |
Accounts Receivable |  | 63,907 |  |  | 34,786 |
Other financial assets |  | 55,204 |  |  | 51,109 |
Total losses for exposures |  | 566,700 |  |  | 247,905 |
Off-balance exposures (credit card limits) |  | 18,131 |  |  | 6,228 |
Other off-balance exposures |  | — |  |  | 15,214 |
Total exposures |  | 584,831 |  |  | 269,347 |

X
- Definition The disclosure of the allowance relating to impairments of financial assets due to credit losses. [Refer: Financial assets] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 10 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfAllowanceForCreditLossesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementOfAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration